Last Posted: Oct 18, 2019
- Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019 - An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial.
Goldstein Karen M et al. Trials 2019 Oct 20(1) 576 - Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience.
Vitiello Pietro Paolo et al. Cancers 2019 Oct 11(10) - Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
van Leerdam Monique E et al. Endoscopy 2019 Oct - The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang Yoon-Jung et al. The Medical journal of Australia 2019 Oct - Genetic Screening and Personalized Prevention in Colorectal Cancer.
Steinke-Lange Verena et al. Visceral medicine 2019 Aug 35(4) 226-230 - Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.
Li Gerald et al. Journal of gastrointestinal oncology 2019 Oct 10(5) 831-840 - The missing heritability of familial colorectal cancer.
Schubert Stephanie A et al. Mutagenesis 2019 Oct - Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center.
Chiaravalli A M et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019 Oct - [Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].
Chen Gong et al. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2017 Jan 20(1) 28-33
.png)
No hay comentarios:
Publicar un comentario